MSL
MED icon

Mackay Shields LLC’s Medifast MED Stock Holding History

Mackay Shields LLC’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-11,900
Closed -$2.52M – 1066
2021
Q1 		$2.52M Sell
11,900
-8,000
-40% -$1.91M 0.02% 675
2020
Q4 		$3.91M Sell
19,900
-600
-3% -$106K 0.03% 562
2020
Q3 		$3.37M Buy
20,500
+3,500
+21% +$576K 0.02% 557
2020
Q2 		$2.36M Buy
+17,000
New +$1.56M 0.02% 679
2019
Q1 		– Sell
-11,600
Closed -$1.45M – 1417
2018
Q4 		$1.45M Buy
+11,600
New +$1.98M 0.01% 787

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Mackay Shields LLC's MED Position: Q2 2021 in Review

Mackay Shields LLC sold out of Medifast (MED) in Q2 2021, closing a stake of 11,900 shares — an estimated $2.52M sold.

Mackay Shields LLC first reported a position in MED in Q4 2018 and held it in 5 quarters. The position peaked at $3.91M in Q4 2020. 301 funds tracked by Wall St. Rank hold MED as of Q2 2021.

  • Mackay Shields LLC reported no remaining Medifast position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 11,900 Medifast shares in Q2 2021, an estimated $2.52M.
  • Mackay Shields LLC first reported a position in Medifast in Q4 2018 and held it in 5 quarters.
  • Mackay Shields LLC's Medifast position peaked at $3.91M in Q4 2020.
  • 301 funds tracked by Wall St. Rank held Medifast as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.